FDA
label_change
· 2021-07-15
FDA Approved: GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR — Supplemental Application (Xeris Pharmaceuticals, Inc.)
Summary
FDA approved a supplemental application for GVOKE HYPOPEN 0.5 mg auto-injector (glucagon injection, solution) by Xeris Pharmaceuticals, updating labeling for th…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR (GLUCAGON INJECTION, SOLUTION)